New strategies in myocardial preservation

Current Opinion in Cardiology

Volumn 12, Issue 6, 1997, Pages 504-514

  Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; PROTON; SODIUM ION;

CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CELL FUNCTION; CONDITIONING; CORONARY ARTERY SURGERY; ENDOTHELIUM CELL; HEART ARREST; HEART FUNCTION; HEART PROTECTION; HEART SURGERY; HYPERPOLARIZATION; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; REVIEW;

EID: 0030806674     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199711000-00002     Document Type: Review

References (56)

1. Lee J, Gates RN, Laks H, Drinkwater DC, Rhudis E, Aharon A, Ardehali A, Chang P: A comparison of distribution between simultaneously or sequentially delivered antegrade retrograde blood cardioplegia. J Card Surg 1996, 11:111-115.
2. Shirai T, Rao V, Weisel RD, Ikonomidis JS, Hayashida, Ivanov J, Carson S, Mohabeer MK, Mickle DAG: Antegrade and retrograde cardioplegia: alternate or simultaneous? J Thorac Cardiovasc Surg 1996, 112:787-796.
3. Gundry SR, Wang N, Sciolaro CM, Arsdell GSV, Razzouk AJ, Hill AC, Bailey LL: Uniformity of perfusion in all regions of the human heart by warm continuous retrograde cardioplegia. Ann Thorac Surg 1996, 61:33-35.
4. Arom KV, Emery RW, Petersen RJ, Bero JW: Evaluation of 7,000+ patients with two different routes of cardioplegia. Ann Thorac Surg 1997, 63:1619-1624. Clinical comparison of antegrade versus antegrade/retrograde cardioplegia in a particularly large patient population.
5. Hayashida N, Weisel RD, Shirai T, Ikonomidis JS, Ivanov J, Carson SM, Mohabeer MK, Tumiati LC, Mickle DAG: Tepid antegrade and retrograde cardioplegia. Ann Thorac Surg 1995, 59:723-729.
6. Engelman RM, Pleet AB, Rousou JA, Flack JE, Deaton DW, Gregory CA, Pekow PS: What is the best perfusion temperature for coronary revascularization? J Thorac Cardiovasc Surg 1996, 112:1622-1633. Report of an improved neurologic protection after tepid heart surgery compared with cold and warm temperatures.
7. Christakis GT, Lichtenstein SV, Buth KJ, Fremes SE, Weisel RD, Naylor CD: The influence of risk on the results of warm heart surgery: a substudy of a randomized trial. Eur J Cardiothoracic Surg 1997, 11:515-520. Unanticipated finding that warm blood cardioplegia is not of greater benefit in high-risk patients than in other risk categories.
8. Menasché Ph: Blood cardioplegia: do we still need to dilute? Ann Thorac Surg 1996, 62:957-960.
9. 31P magnetic resonance study in isolated pig hearts. J Thorac Cardiovasc Surg 1997, 113:1068-1080.
10. Larsen TS, Irtun O, Steigen TK, Andreasen TV, Sorlie D: Myocardial substrate oxidation during warm continuous blood cardioplegia. Ann Thorac Surg 1996, 62:762-768.
11. Reed MK, Barak C, Malloy CR, Maniscalco SP, Jessen ME: Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest J Thorac Cardiovasc Surg 1996, 112:1651-1660.
12. Tsukube T, McCully JD, Federman M, Krukenkamp IB, Levitsky S: Developmental differences in cytosolic calcium accumulation associated with surgically induced global ischemia: optimization of cardioplegic protection and mechanism of action. J Thorac Cardiovasc Surg 1996, 112:175-184. Evidence for an increase in ischemia-induced calcium accumulation and parallel impairment of function in the senescent myocardium.
13. Hayashida N, Isomura T, Sato T, Maruyama H, Higashi, Akasu I, Kosuga K, Aoyagi S: Undiluted tepid blood cardioplegia. Circulation 1996, 94(suppl1):1-599.
14. Louagie YAG, Gonzalez E, Jamart J, Malhomme B, Broka S, Bucrie M, Eucher PH, Schoevaerdts JC: Assessment of continuous cold blood cardioplegia in coronary artery bypass grafting. Ann Thorac Surg 1997, 63:689-696.
15. Alkhulaifi AM, Yellon DM, Pugsley WB: Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg 1994, 8:270-276.
16. Valen G, Takeshima S, Vaage J: Preconditioning improves cardiac function after global ischemia, but not after cold cardioplegia. Ann Thorac Surg 1996, 62:1397-1403.
17. Ogino H, Smolenski RT, Zych M, Seymour AML, Yacoub MH: Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest. Ann Thorac Surg 1996, 62:469-474.
18. Karck M, Rahmanian P, Haverich A: Ischemic preconditioning enhances donor heart preservation. Transplantation 1996, 62:17-22.
19. Asimakis GK, Lick SD, Conti VR: Transient ischemia cannot precondition the rabbit heart against postischemic contratile dysfunction. Ann Thorac Surg 1996, 62:543-549.
20. Cleveland JC, Meldrum DR, Rowland RT, Banerjee A, Harken AH: Preconditioning and hypothermic cardioplegia protect human heart equally against ischemia. Ann Thorac Surg 1997, 63:147-152. Clear demonstration that preconditioning of human myocardium is only effective in situations of unprotected ischemia.
21. Perrault LP, Menasché Ph, Bel A, de Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic JM: Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg 1996, 112:1378-1386.
22. Hutter JJ, Mestril R, Tam EKW, Sievers RE, Dillmann WH, Wolfe CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 1996, 94:1408-1411.
23. Kaukoranta PK, Lepojarvi MPK, Ylitalo KV, Kiviluoma KT, Peuhkurinen KJ: Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 1997, 63:1268-1274. Clinical demonstration that ischemic preconditioning is not of benefit before warm blood cardioplegia.
24. Zellner JL, Hebbar L, Crawford FA, Mukherjee R, Spinale FG: Beneficial effects of myocyte preconditioning on contractile processes after cardioplegic arrest Ann Thorac Surg 1996, 61:558-564.
25. Burns PG, Krukenkamp IB, Caldarone CA, Kirvaitis RJ, Gaudette GR, Levitsky S: Is the preconditioning response conserved in senescent myocardium? Ann Thorac Surg 1996, 61:925-929.
26. Brooks G, Hearse DJ: Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res 1996, 79:627-630.
27. Lee HT, Lafaro RJ, Reed GE: Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995, 10:665-676.
28. Cox MH, Seun-Jun O, Hebbar L, Mukherjee R, Crawford FA, Spinale FG: Protective effects of adenosine on myocyte contractility during cardioplegic arrest. Ann Thorac Surg 1997, 63:981-987.
29. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, Terzic A: Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg 1997, 63:153-161.
30. Meldrum DR, Cleveland JC, Sheridan BC, Rowland RT, Banerjee A, Harken AH: Cardiac preconditionning with calcium: clinically accessible myocardial protection. J Thorac Cardiovasc Surg 1996, 112:778-786.
31. Cope JT, Mauney MC, Banks D, Binns OAR, Moore CL, Rentz JJ, Shockey KS, King RC, Kron IL, Tribble CG: Intravenous phenylephrine preconditioning of cardiac grafts form non-heart-beating donors. Ann Thorac Surg 1997, 63:1664-1668.
32. Menasché Ph, Mouas CH, Grousset Ch: Is potassium channel opening an effective form of preconditioning before cardioplegia? Ann Thorac Surg 1996, 61:1764-1768.
33. Cleveland CJ, Meldrum DR, Cain BS, Banerjee A, Harken AH: Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation 1997, 96:29-32. A study that provides indirect but strong evidence for the involvement of potassium channels in the mediation of preconditioning in man in that this response is abolished in patients receiving preoperative potassium channel-blocking hypoglycemic agents.
34. Schultz J, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glubenclamide-sensitive mechanism in the rat heart. Circ Res 1996, 78:1100-1104. A clinically relevant experimental paper that raises the intriguing hypothesis that the cardioprotective effects of ischemic preconditioning can be mimicked by morphine.
35. Amrani M, Corbett J, Boateng SY, Dunn MJ, Yacoub MH: Kinetics of induction and protective effect of heat-shock proteins after cardioplegic arrest. Ann Thorac Surg 1996, 61:1407-1412. A paper which shows in a rat model simulating the transplant situation that peak levels of heat shock proteins are temporally related to optimal recovery of function and, consequently, emphasizes the need to develop clinically usable means of inducing the relevant gene changes.
36. Lawton JS, Harrington GC, Allen CT, Hsia PW, Damiano RJ: Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996, 61:1680-1688.
37. Lawton JS, Sepic JD, Allen CT, Hsia PW, Damiano RJ: Myocardial protection with potassium-channel openers is as effective as St. Thomas's solution in the rabbit heart. Ann Thorac Surg 1996, 62:31-39.
38. Lawton JS, Hsia PW, Allen CT, Damiano RJ: Myocardial protection in the acutely injured heart: hyperpolarizing versus depolarizing hypothermic cardioplegia. J Thorac Cardiovasc Surg 1997, 113:567-575. A study that provides further insights into the potential use of potassium channel openers as cardioplegic agents.
39. Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A: Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996, 112:820-831. An elegantly designed study that suggests that the major undesirable effect of potassium-induced depolarized arrest (calcium overload) can be prevented by a pre- and concomitant exposure to hyperpolarizing agents like potassium channel openers. This combination might represent a true conceptual breakthrough.
40. Myers ML, Karmazyn M: Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann Thorac Surg 1996, 61:1400-1406. A study that provides further convincing evidence for the cardioprotective effects of a blockade of the sodium-hydrogen exchanger. This effect is most likely mediated by a decrease in calcium accumulation and, in this study, appears to be relevant to the transplant situation.
41. Koike A, Akita T, Hotta Y, Takeya K, Kodama I, Murase M, Abe T, Toyama J: Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy. J Thorac Cardiovasc Surg 1996, 112:765-775.
42. He GW, Yang CQ, Yang JA: Depolarizing cardiac arrest and endothelium-derived hyperpolarizing factor-mediated hyperpolarization and relaxation in coronary arteries: the effect and mechanism. J Thorac Cardiovasc Surg 1997, 113:932-941.
43. Verrier ED, Boyle EM: Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996, 62:915-922.
44. Gohra H, Tsuboi H, Sasaki G, Minami Y, Hamano K, Katoh T, Fujimura Y, Esato K: Effect of cardioplegic arrest and reperfusion on coronary reserve and autoregulation. Ann Thorac Surg 1996, 62:744-749.
45. Mizuno A, Baretti R, Buckberg GD, Young HH, Vinten-Johansen J, Ma XL, Ignarro LJ: Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of I-arginine blood cardioplegia. J Thorac Cardiovasc Surg 1997, 113:379-389.
46. Sato H, Zhao ZQ, Jordan JE, Todd JC, Riley RD, Taft CS, Hammon JW, Li P, Ma XL, Vinten-Johansen J: Basal nitric oxide expresses endogenous cardioprotection during reperfusion by inhibition of neutrophil-mediated damage after surgical revascularization. J Thorac Cardiovasc Surg 1997, 113:399-409.
47. Carrier M, Khalil A, Tourigny A, Solymoss BC, Pelletier LC: Effect of I-arginine on metabolic recovery of the ischemic myocardium. Ann Thorac Surg 1996, 61:1651-1657.
48. Wehberg KE, Foster AH, Wise RM, McLaughlin JS, Brunner MJ: Nitric oxide mediates fluid accumulation during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996, 112:168-174. An elegantly designed experimental study that suggests that I-arginine could reduce fluid accumulation during cardiopulmonary bypass.
49. Katayama O, Ledingham JM, Amrani M, Smolenski RT, Lachno DR, Jayakumar J, Yacoub MH: Functional and metabolic effects of adenosine in cardioplegia: role of temperature and concentration. Ann Thorac Surg 1997, 63:449-455.
50. Mehlhorn U, Allen SJ, Adams DL, Davis KL, Gogola GR, Warters RD: Cardiac surgical conditions induced by β-blockade: effect on myocardial fluid balance. Ann Thorac Surg 1996, 62:143-150. This study shows that compared with blood cardioplegia, maintenance of cardiac contraction reduces myocardial edema and concomitantly improves preservation of function. As such, it provides a sound rationale for beating-heart surgery.
51. Perrault LP, Bel A, de Chaumaray T, Paris B, Bchir A, Bourgeois F, Moalic JM, Menasché Ph: Beating heart coronary artery bypass surgery is associated with increased myocardial production of heat shock proteins [abstract]. Circulation 1996, 94:1170.
52. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL: Myocardium is major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996, 112:806-811. A clinical study which shows that the ischemic/reperfused myocardium contributes to the inflammatory response elicited by cardiopulmonary bypass.
53. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, Taniguchi K, Matsuda H: Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 1996, 111:29-35.
54. Deng MC, Dasch B, Erren M, Möllhoff T, Scheid HH: Impact of left ventricular dyfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 1996, 62:184-190.
55. Lazar HL, Zhang X, Hamasaki T, Memmelo CA, Treanor P, Rivers S, Aldea GS, Bernard SA, Shemin RJ: Heparin-bonded circuits decrease myocardial ischemic damage: an experimental study. Ann Thorac Surg 1997, 63:1701-1705.
56. Miura T, Nelson DP, Schermerhorn ML, Shin'oka T, Zund G, Hickey PR, Neufeld EJ, Mayer JE: Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts. Ann Thorac Surg 1996, 62:1295-1300.